ログイン

HISTOPATHOLOGY
69問 • 2年前
  • Yves Laure Pimentel
  • 通報

    問題一覧

  • 1

    protective response of the body to irritation or injury it is composed of series of physiologic and morphologic changes in the blood vessels, blood components and surrounding connective tissues for the purpose of protecting the body against injury.

    Inflammation

  • 2

    arteriolar and capillary dilation with increased rate of blood flow towards the site of injury

    Rubor/ Redness

  • 3

    it is due to increased capillary permeability causing extravasation of blood fluid

    tumor/ swelling

  • 4

    due to pressure upon the sensory nerve by the exudate/tumor

    Dolor/Pain

  • 5

    study of suffering or structural and functional changes in cells, tissues, and organs that underlies disease

    pathology

  • 6

    destruction of the functioning units of the tissue

    functio laesa/ loss of function

  • 7

    due to transfer of internal heat to surface or site of injury brought about by increased blood content

    calor/heat

  • 8

    fluids escape to the cavities

    exudation

  • 9

    excess fluid in body cabities (transudate/exudate)

    edema

  • 10

    inflammatory exudate high in wbc and parenchymal cell debris

    pus

  • 11

    it represents an intergrade between acute and chronic

    subchronic

  • 12

    are serum like substance/ effusion (no cells)

    serous

  • 13

    local collection of purulent inflammation tissue with liquefactive necrosis

    abscess

  • 14

    ope sorr if skin, eyes, mucous membrane cayse by abrasion and maintained by infection / inflammation

    ulcer

  • 15

    fibrin like substance (seen in severe injuries)

    fibrous

  • 16

    inflammation of the mucus membrane (hypersecretion of mucusa)

    catarrhal

  • 17

    rupture of blood vessels( escape of rbcs)

    hemorrhagic

  • 18

    with pus(wbc, necrotic cells) caused by pyogenic bacteria

    suppurative or purulent inflammation

  • 19

    inflammation in extracellular fluid eith high protein and much cellular debris

    exudate (SG >1.020)

  • 20

    fluid with low protein because of hydrostatic imbalance across vascular endothelium

    Transudate ( SG <1.020)

  • 21

    Vascular and fibroblastic, repeated Increase mononuclears Persistence: Weeks/years

    Chronic

  • 22

    Local, rapid, vascular and exudate By microbial, immunological, physical, chemical causes Increase PMNs Short time ( Day- weeks)

    Acute inflammation

  • 23

    organ or tissues smaller than normal

    Retrogressive Changes

  • 24

    failure of an organ to have an opening

    atresia

  • 25

    Incomplete or defective development of a tissue or organ Most commonly seen in one paired structures (kidney, adrenals) Represented onky by a mass of fatty or fibrous tissue

    Aplasia

  • 26

    Non appearance of an organ

    agenesia

  • 27

    failure of an organ to reach its full mature size

    hypoplasia

  • 28

    Decrease in size of a normally mature tissue or organ, decrease functions but not dead Decrease cell size (loss of cell substance) Decrease cell number

    Atrophy

  • 29

    occurs a natural consequence of maturation

    physiologic

  • 30

    as a consequence of disease

    pathologic

  • 31

    Organ/Tissues larger than Normal

    Progressive Changes

  • 32

    Increase in size because of increased size of cell ( increase size of organelles) -Increase functional demand -Hormonal stimulation

    Hypertrophy

  • 33

    Increase in size because of increase in the number of cells Can be physiological or pathological Occur in cells synthesize DNA

    Hyperplasia

  • 34

    tissue has abnormalities

    Degenerative

  • 35

    One cell type to another ( Adaptive or reversible)

    metaplasia

  • 36

    (atypical hyperplasia) Change of structural components (size, shape, orientation of cell)

    Dysplasia

  • 37

    (Dedeferensation)- Criterion toward malignancy ( Change to a kore primitive embryonic cell type

    anaplasia

  • 38

    Continuous abnormal proliferation of cells withoy control ( tumor)

    neoplasia

  • 39

    establish estimate of aggresiveness or level of maligancy based on the the cytologic differentiation of tumor cells and the number of mitosis within the tumor

    Grading of tumor

  • 40

    Cessation of the vital functions of the brain, heart and lungs Irreversible

    Somatic death

  • 41

    First demonstrable change observed. Cooling of the body, 2-2.5F/hr Not reliable for time of death due to many factors

    Algor mortis

  • 42

    Stiffening of skeletal muscle after deat. 2-3 hours of death (Head and neck) - Decrease ATP and high lactic acid - Locked chemical bridges between actin and myosin ( 12 hours)

    Rigor mortis

  • 43

    Lividity/Suggilations , Purplish discoloration ( due to gravity) After 10-12 hours Settling of blood

    Livor Mortis

  • 44

    Clotting on the large vessels

    Post Mortem clot

  • 45

    Drying, wrinkling of cornea and anterior chamber of the eyes

    Dessication

  • 46

    Release of foul odor due to increase of saprophytic organisms

    Putrefaction

  • 47

    Self destruction of cells

    Autolysis

  • 48

    UICC

    International Union Against Cancer

  • 49

    AJCS

    American Joint Committee on Cancer Staging

  • 50

    Due to injurious agent or stress Cellular response to injurious stimulu depends on type of injury, duration and severity Consequences of cell injury depend on the type and adaptability of injured cells

    Cell Injury

  • 51

    Cell dies due to internal suicide program (programmed cell death)

    Apoptosis

  • 52

    Cellular Death Because of exogenous stimuli Destroyed organelles Cell swelling, protein denaturation and coagulation of proteins Cell Rupture

    Necrosis

  • 53

    destroyed by leukocytes

    Heterolysis

  • 54

    self destruction

    Autolysis

  • 55

    Major pathway (due to Ischemia, Toxin, Infection, Trauma) Enzyme leakage ( lysosomes)- enter and digest cell

    Necrosis

  • 56

    increase basophilia, small nuclei

    pyknosis

  • 57

    Decrease basophilia, faint dissolved nuclei

    Karyolysis

  • 58

    Nuclear fragmentation

    Karyorrhexis

  • 59

    Encountered in Tuberculosis cases Cheese-like (yellow) Granuloma

    Caseous necrosis

  • 60

    fat destroyed by lioase Calcium soaps= chalky white areas ( fat saponification)

    Fat necrosis

  • 61

    decrease of blood flow altered vessels

    Ischemia

  • 62

    Decrease Oxygen Deacrse HgB

    Hypoxia

  • 63

    metabolites of toxic goes to target cells

    chemical injury

  • 64

    internal suicide program (programmed) Decrease cell size Chromatin condensation Cytoplasmic blebs and apoptotic bodies Increase mitochondrial permeability

    Apoptosis

  • 65

    Common type of necrosis Denatured cytoplasmic proteins In solid organs Characterized by infarcts "Buckling effect"-> M.I

    Coagulative necrosis

  • 66

    In limbs .Limb losy blood supply (Coagulative necrosis, "dry gangrene") If with bacteria ( Wet gangrene)

    Fat Necrosis

  • 67

    Seen in soft focal l bacteria Id hetero/ autolysis WINS Area =soft and with fluid raw

    absesses

  • 68

    Seen in softal bacteria Id hetero/ autolysis WINS Area =soft and with fluid raw as abscess Hypoxia (brain)

    liquefactive necrosis

  • 69

    new growth, tumor (with parenchyma and stroma)

    Neoplasia

  • other names parasitology

    other names parasitology

    Yves Laure Pimentel · 70問 · 2年前

    other names parasitology

    other names parasitology

    70問 • 2年前
    Yves Laure Pimentel

    PARASITOLOGY

    PARASITOLOGY

    Yves Laure Pimentel · 111問 · 2年前

    PARASITOLOGY

    PARASITOLOGY

    111問 • 2年前
    Yves Laure Pimentel

    HTMLBE

    HTMLBE

    Yves Laure Pimentel · 64問 · 2年前

    HTMLBE

    HTMLBE

    64問 • 2年前
    Yves Laure Pimentel

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    Yves Laure Pimentel · 61問 · 2年前

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    CC - 1 LAB. SAFETY, BASIC UNITS, AND CONVERSION FACTOR

    61問 • 2年前
    Yves Laure Pimentel

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    Yves Laure Pimentel · 100問 · 2年前

    CC-2 SPECTROPHOTOMETRY

    CC-2 SPECTROPHOTOMETRY

    100問 • 2年前
    Yves Laure Pimentel

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    Yves Laure Pimentel · 41問 · 2年前

    CC-3 ELECTROPHORESIS

    CC-3 ELECTROPHORESIS

    41問 • 2年前
    Yves Laure Pimentel

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    Yves Laure Pimentel · 87問 · 2年前

    AUBF LAB SAFETY

    AUBF LAB SAFETY

    87問 • 2年前
    Yves Laure Pimentel

    CSF 1

    CSF 1

    Yves Laure Pimentel · 100問 · 2年前

    CSF 1

    CSF 1

    100問 • 2年前
    Yves Laure Pimentel

    CSF 2

    CSF 2

    Yves Laure Pimentel · 82問 · 2年前

    CSF 2

    CSF 2

    82問 • 2年前
    Yves Laure Pimentel

    SEMEN 1

    SEMEN 1

    Yves Laure Pimentel · 100問 · 2年前

    SEMEN 1

    SEMEN 1

    100問 • 2年前
    Yves Laure Pimentel

    SEMEN 2

    SEMEN 2

    Yves Laure Pimentel · 7問 · 2年前

    SEMEN 2

    SEMEN 2

    7問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    Yves Laure Pimentel · 100問 · 2年前

    SYNOVIAL FLUID 1

    SYNOVIAL FLUID 1

    100問 • 2年前
    Yves Laure Pimentel

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    Yves Laure Pimentel · 6問 · 2年前

    SYNOVIAL FLUID 2

    SYNOVIAL FLUID 2

    6問 • 2年前
    Yves Laure Pimentel

    SEROUS FLUID

    SEROUS FLUID

    Yves Laure Pimentel · 25問 · 2年前

    SEROUS FLUID

    SEROUS FLUID

    25問 • 2年前
    Yves Laure Pimentel

    PLEURAL FLUID

    PLEURAL FLUID

    Yves Laure Pimentel · 44問 · 2年前

    PLEURAL FLUID

    PLEURAL FLUID

    44問 • 2年前
    Yves Laure Pimentel

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    Yves Laure Pimentel · 18問 · 2年前

    PERICARDIAL FLUID

    PERICARDIAL FLUID

    18問 • 2年前
    Yves Laure Pimentel

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    Yves Laure Pimentel · 30問 · 2年前

    PERITONEAL FLUID/ ASCITIC FLUID

    PERITONEAL FLUID/ ASCITIC FLUID

    30問 • 2年前
    Yves Laure Pimentel

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    Yves Laure Pimentel · 92問 · 2年前

    AMNIOTIC FLUID

    AMNIOTIC FLUID

    92問 • 2年前
    Yves Laure Pimentel

    FECALYSIS

    FECALYSIS

    Yves Laure Pimentel · 80問 · 2年前

    FECALYSIS

    FECALYSIS

    80問 • 2年前
    Yves Laure Pimentel

    問題一覧

  • 1

    protective response of the body to irritation or injury it is composed of series of physiologic and morphologic changes in the blood vessels, blood components and surrounding connective tissues for the purpose of protecting the body against injury.

    Inflammation

  • 2

    arteriolar and capillary dilation with increased rate of blood flow towards the site of injury

    Rubor/ Redness

  • 3

    it is due to increased capillary permeability causing extravasation of blood fluid

    tumor/ swelling

  • 4

    due to pressure upon the sensory nerve by the exudate/tumor

    Dolor/Pain

  • 5

    study of suffering or structural and functional changes in cells, tissues, and organs that underlies disease

    pathology

  • 6

    destruction of the functioning units of the tissue

    functio laesa/ loss of function

  • 7

    due to transfer of internal heat to surface or site of injury brought about by increased blood content

    calor/heat

  • 8

    fluids escape to the cavities

    exudation

  • 9

    excess fluid in body cabities (transudate/exudate)

    edema

  • 10

    inflammatory exudate high in wbc and parenchymal cell debris

    pus

  • 11

    it represents an intergrade between acute and chronic

    subchronic

  • 12

    are serum like substance/ effusion (no cells)

    serous

  • 13

    local collection of purulent inflammation tissue with liquefactive necrosis

    abscess

  • 14

    ope sorr if skin, eyes, mucous membrane cayse by abrasion and maintained by infection / inflammation

    ulcer

  • 15

    fibrin like substance (seen in severe injuries)

    fibrous

  • 16

    inflammation of the mucus membrane (hypersecretion of mucusa)

    catarrhal

  • 17

    rupture of blood vessels( escape of rbcs)

    hemorrhagic

  • 18

    with pus(wbc, necrotic cells) caused by pyogenic bacteria

    suppurative or purulent inflammation

  • 19

    inflammation in extracellular fluid eith high protein and much cellular debris

    exudate (SG >1.020)

  • 20

    fluid with low protein because of hydrostatic imbalance across vascular endothelium

    Transudate ( SG <1.020)

  • 21

    Vascular and fibroblastic, repeated Increase mononuclears Persistence: Weeks/years

    Chronic

  • 22

    Local, rapid, vascular and exudate By microbial, immunological, physical, chemical causes Increase PMNs Short time ( Day- weeks)

    Acute inflammation

  • 23

    organ or tissues smaller than normal

    Retrogressive Changes

  • 24

    failure of an organ to have an opening

    atresia

  • 25

    Incomplete or defective development of a tissue or organ Most commonly seen in one paired structures (kidney, adrenals) Represented onky by a mass of fatty or fibrous tissue

    Aplasia

  • 26

    Non appearance of an organ

    agenesia

  • 27

    failure of an organ to reach its full mature size

    hypoplasia

  • 28

    Decrease in size of a normally mature tissue or organ, decrease functions but not dead Decrease cell size (loss of cell substance) Decrease cell number

    Atrophy

  • 29

    occurs a natural consequence of maturation

    physiologic

  • 30

    as a consequence of disease

    pathologic

  • 31

    Organ/Tissues larger than Normal

    Progressive Changes

  • 32

    Increase in size because of increased size of cell ( increase size of organelles) -Increase functional demand -Hormonal stimulation

    Hypertrophy

  • 33

    Increase in size because of increase in the number of cells Can be physiological or pathological Occur in cells synthesize DNA

    Hyperplasia

  • 34

    tissue has abnormalities

    Degenerative

  • 35

    One cell type to another ( Adaptive or reversible)

    metaplasia

  • 36

    (atypical hyperplasia) Change of structural components (size, shape, orientation of cell)

    Dysplasia

  • 37

    (Dedeferensation)- Criterion toward malignancy ( Change to a kore primitive embryonic cell type

    anaplasia

  • 38

    Continuous abnormal proliferation of cells withoy control ( tumor)

    neoplasia

  • 39

    establish estimate of aggresiveness or level of maligancy based on the the cytologic differentiation of tumor cells and the number of mitosis within the tumor

    Grading of tumor

  • 40

    Cessation of the vital functions of the brain, heart and lungs Irreversible

    Somatic death

  • 41

    First demonstrable change observed. Cooling of the body, 2-2.5F/hr Not reliable for time of death due to many factors

    Algor mortis

  • 42

    Stiffening of skeletal muscle after deat. 2-3 hours of death (Head and neck) - Decrease ATP and high lactic acid - Locked chemical bridges between actin and myosin ( 12 hours)

    Rigor mortis

  • 43

    Lividity/Suggilations , Purplish discoloration ( due to gravity) After 10-12 hours Settling of blood

    Livor Mortis

  • 44

    Clotting on the large vessels

    Post Mortem clot

  • 45

    Drying, wrinkling of cornea and anterior chamber of the eyes

    Dessication

  • 46

    Release of foul odor due to increase of saprophytic organisms

    Putrefaction

  • 47

    Self destruction of cells

    Autolysis

  • 48

    UICC

    International Union Against Cancer

  • 49

    AJCS

    American Joint Committee on Cancer Staging

  • 50

    Due to injurious agent or stress Cellular response to injurious stimulu depends on type of injury, duration and severity Consequences of cell injury depend on the type and adaptability of injured cells

    Cell Injury

  • 51

    Cell dies due to internal suicide program (programmed cell death)

    Apoptosis

  • 52

    Cellular Death Because of exogenous stimuli Destroyed organelles Cell swelling, protein denaturation and coagulation of proteins Cell Rupture

    Necrosis

  • 53

    destroyed by leukocytes

    Heterolysis

  • 54

    self destruction

    Autolysis

  • 55

    Major pathway (due to Ischemia, Toxin, Infection, Trauma) Enzyme leakage ( lysosomes)- enter and digest cell

    Necrosis

  • 56

    increase basophilia, small nuclei

    pyknosis

  • 57

    Decrease basophilia, faint dissolved nuclei

    Karyolysis

  • 58

    Nuclear fragmentation

    Karyorrhexis

  • 59

    Encountered in Tuberculosis cases Cheese-like (yellow) Granuloma

    Caseous necrosis

  • 60

    fat destroyed by lioase Calcium soaps= chalky white areas ( fat saponification)

    Fat necrosis

  • 61

    decrease of blood flow altered vessels

    Ischemia

  • 62

    Decrease Oxygen Deacrse HgB

    Hypoxia

  • 63

    metabolites of toxic goes to target cells

    chemical injury

  • 64

    internal suicide program (programmed) Decrease cell size Chromatin condensation Cytoplasmic blebs and apoptotic bodies Increase mitochondrial permeability

    Apoptosis

  • 65

    Common type of necrosis Denatured cytoplasmic proteins In solid organs Characterized by infarcts "Buckling effect"-> M.I

    Coagulative necrosis

  • 66

    In limbs .Limb losy blood supply (Coagulative necrosis, "dry gangrene") If with bacteria ( Wet gangrene)

    Fat Necrosis

  • 67

    Seen in soft focal l bacteria Id hetero/ autolysis WINS Area =soft and with fluid raw

    absesses

  • 68

    Seen in softal bacteria Id hetero/ autolysis WINS Area =soft and with fluid raw as abscess Hypoxia (brain)

    liquefactive necrosis

  • 69

    new growth, tumor (with parenchyma and stroma)

    Neoplasia